Background: With a unique influenza season occurring in the midst of a pandemic, there is interest in assessing the role of the influenza vaccine in COVID-19 susceptibility and severity. Methods: In this retrospective cohort study, patients receiving a laboratory test for COVID-19 were identified. The primary outcome was comparison of positive COVID-19 testing in those who received the influenza vaccine versus those who did not. Secondary end points in patients testing positive for COVID-19 included mortality, need for hospitalization, length of stay, need for intensive care, and mechanical ventilation. Results: A total of 27,201 patients received laboratory testing for COVID-19. The odds of testing positive for COVID-19 was reduced in patients who received an influenza vaccine compared to those who did not (odds ratio 0.76, 95% CI 0.68-0.86; P
CITATION STYLE
Conlon, A., Ashur, C., Washer, L., Eagle, K. A., & Hofmann Bowman, M. A. (2021). Impact of the influenza vaccine on COVID-19 infection rates and severity. American Journal of Infection Control, 49(6), 694–700. https://doi.org/10.1016/j.ajic.2021.02.012
Mendeley helps you to discover research relevant for your work.